{"id":12314,"date":"2018-10-12T07:44:13","date_gmt":"2018-10-12T12:44:13","guid":{"rendered":"http:\/\/leavittbrothers.com\/blog\/?p=12314"},"modified":"2018-10-12T07:44:13","modified_gmt":"2018-10-12T12:44:13","slug":"before-the-open-oct-12-7","status":"publish","type":"post","link":"https:\/\/blog.leavittbrothers.com\/?p=12314","title":{"rendered":"Before the Open (Oct 12)"},"content":{"rendered":"<p><span style=\"font-size: medium;\"> Good morning. Happy Friday. <\/span><br \/>\n<span style=\"font-size: medium;\"> The <strong>Asian\/Pacific<\/strong> markets closed with solid gains. China, Hong Kong, South Korea, New Zealand, India, Taiwan, Malaysia and the Philippines did very well. <strong>Europe, Africa and the Middle East<\/strong> are currently mostly up. The UK, France, Germany, Denmark, Poland, Turkey, Russia, Greece, South Africa, Finland and Hungary are doing very well; the UAE, Israel and Saudi Arabia are down. Futures in the <strong>States<\/strong> point towards a huge gap up for the cash market. <\/span><br \/>\n<span style=\"font-size: medium;\"><!--more-->&#8212;&#8212;&#8212;&#8212;&#8212;<br \/>\n<strong> BLOG: <\/strong><a style=\"font-weight: bold; font-size: medium;\" href=\"http:\/\/leavittbrothers.com\/blog\/index.php\/2018\/10\/11\/cci-everything-you-need-to-know\/\">CCI \u2013 Everything You Need to Know<\/a><br \/>\n&#8212;&#8212;&#8212;&#8212;&#8212;<\/span><br \/>\n<span style=\"font-size: medium;\"> The dollar is up. Oil and copper are up. Gold and silver are mixed and little changed. Bonds are down. <\/span><br \/>\n<span style=\"font-size: medium;\"> <strong>Overnight Stock Movers<\/strong> from barchart.com&#8230;<\/span><br \/>\n<span style=\"font-size: medium;\"> JPMorgan Chase (JPM -3.00%) is up 1% in pre-market trading after it reported Q3 adjusted EPS of $2.36, higher than consensus of $2.26.<\/span><br \/>\n<span style=\"font-size: medium;\"> Eastman Chemical (EMN -2.60%) was upgraded to &#8216;Overweight&#8217; from &#8216;Neutral&#8217; at JPMorgan Chase with a price target of $95.<\/span><br \/>\n<span style=\"font-size: medium;\"> IAC\/Interactive (IAC +0.80%) was rated a new &#8216;Buy&#8217; at Nomura Instinet with a price target of $246.<\/span><br \/>\n<span style=\"font-size: medium;\"> Halliburton (HAL -2.19%) was rated a new &#8216;Overweight&#8217; at Stephens with a price target of $55.<\/span><br \/>\n<span style=\"font-size: medium;\"> Match Group (MTCH +1.94%) was rated a new &#8216;Buy&#8217; at Nomura Instinet with a price target of $66.<\/span><br \/>\n<span style=\"font-size: medium;\"> Marvell Technology Group Ltd (MRVL +1.96%) was upgraded to &#8216;Buy&#8217; from &#8216;Hold&#8217; at Stifel with a price target of $21.<\/span><br \/>\n<span style=\"font-size: medium;\"> Abeona Therapeutics (ABEO +0.05%) was rated a new &#8216;Buy&#8217; at Mizuho Securities with a price target of $17.<\/span><br \/>\n<span style=\"font-size: medium;\"> Corium International (CORI -0.24%) surged 30% in after-hours trading after the company was acquired by Gurnet Point for $12.50 a share.<\/span><br \/>\n<span style=\"font-size: medium;\"> Two Harbors Investment (TWO -1.59%) was rated a new &#8216;Outperform&#8217; at Raymond James with a price target of $16.50.<\/span><br \/>\n<span style=\"font-size: medium;\"> Foamix Pharmaceuticals Ltd (FOMX +0.40%) climbed almost 5% in after-hours trading after it was rated a new &#8216;Overweight&#8217; at Cantor Fitzgerald with a price target of $15.<\/span><br \/>\n<span style=\"font-size: medium;\"> Progenics Pharmaceuticals (PGNX -2.79%) rose more than 4% in after-hours trading after it said it will advance its I-131 1095 drug for the treatment of metastatic prostate cancer, into a Phase 2 clinical study.<\/span><br \/>\n<span style=\"font-size: medium;\"> Tetraphase Pharmaceuticals (TTPH -0.83%) jumped more than 12% in after-hours trading after it announced the commercial launch of its Xerava, a new treatment for intra-abdominal infections.<\/span><br \/>\n<span style=\"font-size: medium;\"> Immune Design (IMDZ -1.41%) plunged 22% in after-hours trading after it announced that it will discontinue its &#8220;Synovate&#8221; trial after early analysis of the ongoing Phase 2 trial showed the treatment is not likely to show a survival benefit in relapsed synovial sarcoma patients.<\/span><br \/>\n<span style=\"font-size: medium;\"> <strong>Today&#8217;s Economic Calendar<\/strong><br \/>\n<span style=\"font-size: medium;\"> 8:30 Import\/Export Prices<br \/>\n<span style=\"font-size: medium;\"> 9:30 Fed&#8217;s Evans Speech<br \/>\n<span style=\"font-size: medium;\"> 10:00 Consumer Sentiment<br \/>\n<span style=\"font-size: medium;\"> 00:30 PM Fed&#8217;s Bostic Speech<br \/>\n<span style=\"font-size: medium;\"> 1:00 PM Baker-Hughes Rig Count<br \/>\n<span style=\"font-size: medium;\"> 10:30 PM Randal Quarles Speech<\/span><\/span><\/span><\/span><\/span><\/span><\/span><br \/>\n<span style=\"font-size: medium;\"><strong>Other<\/strong>&#8230;<\/span><br \/>\n<span style=\"font-size: medium;\">today&#8217;s <a href=\"http:\/\/www.briefing.com\/investor\/calendars\/upgrades-downgrades\/\">upgrades\/downgrades<\/a> from briefing.com<\/span><br \/>\n<span style=\"font-size: medium;\">this week&#8217;s <a href=\"http:\/\/www.morningstar.com\/earnings\/earnings-calendar.aspx\">Earnings<\/a><\/span> from Morningstar<br \/>\n<span style=\"font-size: medium;\">this week&#8217;s <a href=\"http:\/\/mam.econoday.com\/\">Economic Numbers\/Reports<\/a><\/span> powered by ECONODAY<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Good morning. Happy Friday. The Asian\/Pacific markets closed with solid gains. China, Hong Kong, South Korea, New Zealand, India, Taiwan, Malaysia and the Philippines did very well. Europe, Africa and the Middle East are currently mostly up. The UK, France, Germany, Denmark, Poland, Turkey, Russia, Greece, South Africa, Finland and Hungary are doing very well; [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2],"tags":[],"_links":{"self":[{"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=\/wp\/v2\/posts\/12314"}],"collection":[{"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12314"}],"version-history":[{"count":0,"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=\/wp\/v2\/posts\/12314\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12314"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12314"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.leavittbrothers.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12314"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}